Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
about
Efficacy of a referral center for patient-centered care in multiple myeloma: a cohort study.Lenalidomide in multiple myeloma.Post-transplant consolidation plus lenalidomide maintenance vs lenalidomide maintenance alone in multiple myeloma: A systematic review.FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma.
P2860
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
@ast
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
@en
Post-Autologous
@nl
type
label
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
@ast
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
@en
Post-Autologous
@nl
prefLabel
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
@ast
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
@en
Post-Autologous
@nl
P2860
P356
P1476
Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
@en
P2093
Zeina Al-Mansour
P2860
P304
P356
10.1155/2014/652395
P577
2014-11-24T00:00:00Z